Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering

(MedPage Today) -- PHILADELPHIA -- A DNA base editing therapy, intended for lifelong lowering of LDL cholesterol, passed initial tests in people with severe, advanced atherosclerotic cardiovascular disease (ASCVD). According to interim results...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news